Morgan Stanley Enzo Biochem Inc Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Enzo Biochem Inc stock. As of the latest transaction made, Morgan Stanley holds 67,342 shares of ENZ stock, worth $37,038. This represents 0.0% of its overall portfolio holdings.

Number of Shares

67,342

Previous 67,342 -0.0%

Holding current value

$37,038

Previous $47,000 48.94%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.7 - $1.17 $3,159 - $5,280	-4,513 Reduced 6.28%	67,342 $47,000
Q3 2024 May 14, 2025	BUY	$1.04 - $1.18 $104 - $118	100 Added 0.14%	71,855 $80,000
Q3 2024 Nov 14, 2024	BUY	$1.04 - $1.18 $104 - $118	100 Added 0.14%	71,855 $80,000
Q2 2024 May 14, 2025	BUY	$1.04 - $1.28 $4,589 - $5,648	4,413 Added 6.55%	71,755 $78,000
Q1 2024 Aug 16, 2024	SELL	$1.21 - $1.5 $4,840 - $6,000	-4,000 Reduced 5.28%	71,755 $91,000
Q1 2024 May 15, 2024	SELL	$1.21 - $1.5 $4,840 - $6,000	-4,000 Reduced 5.28%	71,755 $91,000
Q4 2023 Aug 16, 2024	BUY	$1.21 - $1.44 $4,840 - $5,760	4,000 Added 5.57%	75,755 $105,000
Q4 2023 Feb 13, 2024	BUY	$1.21 - $1.44 $140 - $167	116 Added 0.15%	75,755 $105,000
Q3 2023 Nov 15, 2023	BUY	$1.3 - $1.87 $10,400 - $14,960	8,000 Added 11.83%	75,639 $105,000
Q2 2023 Aug 14, 2023	SELL	$1.84 - $2.66 $189,963 - $274,621	-103,241 Reduced 60.42%	67,639 $124,000
Q1 2023 May 15, 2023	SELL	$1.0 - $2.51 $196,422 - $493,019	-196,422 Reduced 53.48%	170,880 $415,000
Q4 2022 Feb 14, 2023	SELL	$1.16 - $2.42 $25,399 - $52,988	-21,896 Reduced 5.63%	367,302 $525,000
Q3 2022 Nov 14, 2022	SELL	$2.1 - $2.73 $66,271 - $86,153	-31,558 Reduced 7.5%	389,198 $867,000
Q2 2022 Oct 27, 2022	SELL	$2.0 - $3.0 $134,838 - $202,257	-67,419 Reduced 13.81%	420,756 $871,000
Q2 2022 Aug 15, 2022	SELL	$2.0 - $3.0 $134,838 - $202,257	-67,419 Reduced 13.81%	420,756 $871,000
Q1 2022 Oct 27, 2022	BUY	$2.9 - $3.47 $195,515 - $233,943	67,419 Added 16.02%	488,175 $1.42 Million
Q1 2022 May 13, 2022	BUY	$2.9 - $3.47 $1.36 Million - $1.63 Million	469,272 Added 2482.53%	488,175 $1.42 Million
Q4 2021 Feb 14, 2022	BUY	$3.17 - $4.09 $21,102 - $27,227	6,657 Added 54.36%	18,903 $60,000
Q3 2021 Nov 15, 2021	BUY	$3.01 - $3.77 $36,860 - $46,167	12,246 New	12,246 $44,000

Others Institutions Holding ENZ

# of Institutions

Shares Held

16.3M

Call Options Held

Put Options Held

View Full List

About ENZO BIOCHEM INC

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $26.8M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

More about ENZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account